Safety and efficacy of HSCT for systemic sclerosis across clinical trials
Nat Rev Rheumatol
.
2020 Nov;16(11):661.
doi: 10.1038/s41584-020-0493-2.
Authors
Lynette Keyes-Elstein
1
,
Erica Brittain
2
,
Ashley Pinckney
1
,
Ellen A Goldmuntz
2
,
Keith M Sullivan
3
Affiliations
1
Rho Federal Systems, Durham, NC, USA.
2
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
3
Duke University Medical Center, Durham, NC, USA. keith.sullivan@duke.edu.
PMID:
32855553
DOI:
10.1038/s41584-020-0493-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Hematopoietic Stem Cell Transplantation*
Humans
Scleroderma, Systemic* / drug therapy
Transplantation, Autologous